Form 8-K - Current report:
SEC Accession No. 0001193125-21-358541
Filing Date
2021-12-16
Accepted
2021-12-16 07:11:34
Documents
21
Period of Report
2021-12-16
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d242360d8k.htm   iXBRL 8-K 24737
2 EX-99.1 d242360dex991.htm EX-99.1 10330
6 GRAPHIC g242360ex99_1p1g1.jpg GRAPHIC 266805
7 GRAPHIC g242360ex99_1p2g1.jpg GRAPHIC 526842
8 GRAPHIC g242360ex99_1p3g1.jpg GRAPHIC 388185
9 GRAPHIC g242360ex99_1p4g1.jpg GRAPHIC 306998
10 GRAPHIC g242360ex99_1p5g1.jpg GRAPHIC 303879
11 GRAPHIC g242360ex99_1p6g1.jpg GRAPHIC 219946
12 GRAPHIC g242360ex99_1p7g1.jpg GRAPHIC 270330
13 GRAPHIC g242360ex99_1p8g1.jpg GRAPHIC 225160
  Complete submission text file 0001193125-21-358541.txt   3620508

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rgen-20211216.xsd EX-101.SCH 2905
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgen-20211216_lab.xml EX-101.LAB 18909
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgen-20211216_pre.xml EX-101.PRE 11872
14 EXTRACTED XBRL INSTANCE DOCUMENT d242360d8k_htm.xml XML 3513
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

EIN.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-14656 | Film No.: 211495990
SIC: 2836 Biological Products, (No Diagnostic Substances)